Zentek (ZTEK) Liabilities and Shareholders Equity (2021 - 2026)
Zentek (ZTEK) posted Liabilities and Shareholders Equity of $11.0 million for Q1 2026, down 11.75% sequentially from $12.5 million in Q4 2025, and down 14.19% YoY from $12.8 million in Q1 2025.
Zentek (ZTEK) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Zentek has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $11.0 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 14.19% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.1 million (down 14.37% YoY) and the FY2026 annual result came in at $10.9 million, down 17.5% from the prior year.
- Liabilities and Shareholders Equity retreated to $11.0 million in Q1 2026 per ZTEK's latest filing, from $12.5 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $35.5 million in Q1 2022 and troughed at $11.0 million in Q1 2026.
- A 5-year average of $18.7 million and a median of $16.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity soared 260.61% in 2022, then tumbled 33.54% in 2024.
- Over 5 years, Liabilities and Shareholders Equity stood at $21.3 million in 2022, then declined by 14.53% to $18.2 million in 2023, then slipped by 25.32% to $13.6 million in 2024, then slipped by 8.47% to $12.5 million in 2025, then dropped by 11.75% to $11.0 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $11.0 million, $12.5 million, and $12.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Zentek | 63.90 Mn | 51.90 Mn | - | 22.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.00 Mn |
| Dec 31, 2025 | 12.47 Mn |
| Sep 30, 2025 | 12.26 Mn |
| Jun 30, 2025 | 13.34 Mn |
| Mar 31, 2025 | 12.82 Mn |
| Dec 31, 2024 | 13.62 Mn |
| Sep 30, 2024 | 15.58 Mn |
| Jun 30, 2024 | 15.28 Mn |
| Mar 31, 2024 | 16.76 Mn |
| Dec 31, 2023 | 18.24 Mn |
| Sep 30, 2023 | 20.50 Mn |
| Jun 30, 2023 | 22.98 Mn |
| Mar 31, 2023 | 24.62 Mn |
| Dec 31, 2022 | 21.34 Mn |
| Sep 30, 2022 | 24.06 Mn |
| Jun 30, 2022 | 27.69 Mn |
| Mar 31, 2022 | 35.51 Mn |
| Dec 31, 2021 | 5.92 Mn |
| Mar 31, 2021 | 23.90 Mn |